SARAH NEWHOUSE: Open Payments
NPI 1093496580 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 38 payments from 5 companies in 2025. Trend: 2023 $55 · 2024 $353 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $458 |
| ABBVIE INC. | 13 | $183 |
| Novo Nordisk Inc | 4 | $65 |
| Noven Therapeutics, LLC | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: Auvelity, QULIPTA, Xelstrym, XIFAXAN, Ozempic, Wegovy, Rybelsus.
Industry payments across LA — which companies pay providers there.
